Clinicopathological and prognostic value of SNHG6 in cancers: a systematic review and a meta-analysis.
Ontology highlight
ABSTRACT: BACKGROUND:Dysregulation of the long non-coding RNA small nucleolar RNA host gene 16 (lncRNA SNHG6) has been found in multiple cancers. However, a definite conclusion on the clinical value of lncRNA SNHG6 expression in human cancers has not been determined. The purpose of the present meta-analysis was to comprehensively elucidate the association between SNHG6 expression and clinical outcomes in cancers. METHODS:A systematic search was performed through the PubMed, Web of Science, Chinese National Knowledge Infrastructure (CNKI), and Wangfang databases for relevant studies. The pooled hazard ratios (HRs) with 95% confidence intervals (CIs) were collected to estimate the prognostic value, and the odds ratios (ORs) with 95% CIs were used to evaluate the relationship between lncRNA SNHG6 expression and clinicopathological features, including tumor invasion depth, lymph node metastasis (LNM), distance metastasis (DM), and TNM stage. RESULTS:In total, 914 patients from 13 studies were included in this meta-analysis. The pooled results suggested that evaluated SNHG6 expression could predict an unfavorable overall survival (OS) (HR?=?2.04, 95% CI:1.56-2.52) with no heterogeneity (I2?=?0.0%, p?=?0.996). Subgroup analysis indicated a significant association between high SNHG6 expression and shorter OS in those studies with digestive system cancers (HR?=?2.05, 95% CI: 1.47-2.62), or with sample size
SUBMITTER: Zhang S
PROVIDER: S-EPMC7178593 | biostudies-literature | 2020 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA